Replies to post #926 on Vascular Biogenics Ltd (VBLT)

[gr8db8]

Value ... I thought about the buyer angle as well. It would explain some of the delays ... and perhaps even why they opted not to do the SPA.
But at this point, the company is so close to a key milestone that I am less concerned about what happens in 4Q17 or 2018.